LabGenomics Co., Ltd. (KOSDAQ:084650)
815.00
-8.00 (-0.97%)
Aug 11, 2026, 3:30 PM KST
LabGenomics Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 61,100 | 134,449 | 184,858 | 286,195 | 214,147 | 280,899 | |
Market Cap Growth | -66.27% | -27.27% | -35.41% | 33.64% | -23.76% | 31.47% |
Enterprise Value | 68,695 | 119,105 | 131,426 | 227,829 | 131,079 | 222,858 |
Last Close Price | 823.00 | 1811.00 | 2490.00 | 3855.00 | 3150.00 | 4098.14 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 4.43 | 3.35 |
PS Ratio | 0.73 | 1.53 | 2.15 | 4.03 | 1.48 | 1.39 |
PB Ratio | 0.41 | 0.90 | 0.86 | 1.25 | 1.02 | 1.77 |
P/TBV Ratio | 0.86 | 1.81 | 1.38 | 1.89 | 1.03 | 1.78 |
P/FCF Ratio | - | - | - | - | 6.84 | 5.44 |
P/OCF Ratio | - | - | - | - | 3.11 | 4.30 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.82 | 1.35 | 1.53 | 3.21 | 0.91 | 1.10 |
EV/EBITDA Ratio | - | - | - | - | 1.87 | 2.07 |
EV/EBIT Ratio | - | - | - | - | 1.98 | 2.13 |
EV/FCF Ratio | - | - | - | - | 4.19 | 4.32 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.41 | 0.37 | 0.23 | 0.22 | 0.10 | 0.03 |
Debt / EBITDA Ratio | - | - | - | - | 0.30 | 0.05 |
Debt / FCF Ratio | - | - | - | - | 0.68 | 0.10 |
Net Debt / Equity Ratio | 0.05 | -0.02 | -0.19 | -0.29 | -0.55 | -0.59 |
Net Debt / EBITDA Ratio | -0.17 | 0.06 | 4.57 | 63.70 | -1.65 | -0.87 |
Net Debt / FCF Ratio | -0.25 | 0.08 | 2.44 | 7.42 | -3.70 | -1.81 |
Asset Turnover | 0.32 | 0.34 | 0.28 | 0.25 | 0.64 | 1.29 |
Inventory Turnover | 18.45 | 18.02 | 18.54 | 20.73 | 21.93 | 30.06 |
Quick Ratio | 1.10 | 1.16 | 1.70 | 2.35 | 8.67 | 4.12 |
Current Ratio | 1.17 | 1.24 | 1.78 | 2.47 | 8.77 | 4.20 |
Return on Equity (ROE) | -35.39% | -35.18% | -10.66% | -2.41% | 25.98% | 69.86% |
Return on Assets (ROA) | -12.74% | -13.05% | -3.79% | -1.53% | 18.19% | 41.65% |
Return on Invested Capital (ROIC) | -35.13% | -34.03% | -10.93% | -5.38% | 62.76% | 162.75% |
Return on Capital Employed (ROCE) | -30.70% | -32.30% | -8.40% | -2.80% | 28.70% | 63.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -104.27% | -47.88% | -12.87% | -1.63% | 22.60% | 29.85% |
FCF Yield | -48.69% | -23.56% | -9.01% | -3.08% | 14.62% | 18.39% |
Payout Ratio | - | - | - | - | 6.85% | - |
Buyback Yield / Dilution | -0.46% | -0.46% | 0.46% | -9.63% | -0.20% | -2.61% |